For decades, scientists have wondered why an axolotl can casually regrow an entire leg while a human cannot regrow more than a fingertip. A new study published in the Proceedings of the National Academy of Sciences offers the clearest answer yet — and a tantalizing target for future therapies.
Researchers from Wake Forest University, Duke University and the University of Wisconsin-Madison compared regeneration across three very different animals: the Mexican axolotl salamander, the zebrafish, and the laboratory mouse. By layering data across species, the team identified a shared family of genes — known as SP genes — that switches on during regeneration and appears to coordinate the entire repair program.
"This significant research brought together three labs, working across three organisms to compare regeneration," said Wake Forest assistant professor of biology Josh Currie, whose lab studies the axolotl. "It showed us that there are universal, unifying genetic programs that are driving regeneration in very different types of organisms — salamanders, zebrafish and mice."
The three species were chosen for what each can teach scientists. Axolotls are champion regenerators, capable of replacing entire limbs along with tails, spinal cord tissue and parts of the heart, brain, lungs, liver and jaw. Zebrafish can regrow damaged tail fins again and again, plus repair the heart, kidneys, retinas and pancreas. Mice are far more limited but, like humans, can regrow the very tips of their digits — a sliver of regenerative ability that hints at dormant machinery waiting to be reactivated.
When the team mapped gene activity in the cells that lead the regeneration response, the SP gene family stood out across all three animals. Switching these genes off in the lab disrupted the carefully timed cascade of cell signals that normally allows tissue to rebuild. That suggests SP genes sit near the top of the regulatory hierarchy — closer to a master switch than to a single cog in the machine.
For human medicine, the implications are striking. Around the world, more than one million amputations are performed each year due to vascular disease, traumatic injury, infection and cancer, according to Global Burden of Disease estimates, and that number is expected to grow as populations age. Prosthetics have improved dramatically, but they cannot restore natural sensation, fine motor control or the body's own healing response. Identifying conserved regeneration genes opens a path to drugs or gene therapies that nudge human tissue toward the kind of repair that axolotls perform routinely.
The authors are careful to note that no one is regrowing a human arm any time soon. Many of the steps that follow the SP gene signal — forming a blastema of progenitor cells, patterning the new tissue, growing nerves and blood vessels in lockstep — remain only partially understood. But the new study reframes the search. Instead of hunting for a single magic switch, researchers now have a manageable shortlist of master regulators that appear to do similar work in salamanders, fish and mammals alike.
There is also a deeper biological insight: regeneration is not an exotic trick reserved for a few weird amphibians. It looks more like an ancient program written into many animals, expressed loudly in some and quietly muffled in others. Humans may be carrying a version of that program without using it.
That changes what the goal looks like. Rather than engineering regeneration from scratch, the field may be moving toward something more like reawakening it. With SP genes now flagged as a central pathway, the next experiments will test whether boosting their activity, or restoring the right partner signals, can extend mouse digit regeneration further up the limb. If it works in mice, it becomes a serious candidate for human trials.
For amputees, burn survivors and patients with degenerative diseases, the takeaway is cautiously hopeful: the genetic instructions for rebuilding the body appear to already exist. Scientists are getting much better at reading them.
